Return to Article Details
EFFECT OF EMPAGLIFLOZIN ON CARDIAC REMODELING IN PATIENTS WITH TYPE 2 DIABETES AND HEART FAILURE WITH REDUCED EJECTION FRACTION
Download
Download PDF